Spotlight Innovation Closes $2.5 Million Financing

WEST DES MOINES, IA--(Marketwired - Apr 28, 2015) - Spotlight Innovation Inc. (the "Company") (OTCQB: STLT) announces that it has closed on an unsecured convertible promissory note in the gross principal amount of $2,500,000, exclusive of certain fees. The Note has a maturity date of March 27, 2020, and bears interest at the rate of Prime plus five percent (5%) during the first 36 months, increasing to an interest of Prime plus six percent (6%) for the remaining 24 months. The Note is convertible into shares of common stock of the Company at a price of $1.50 per share.

The Company also issued warrants (the "Warrants") to purchase 250,000 shares of common stock of the Company. The Warrants have a five-year term and are exercisable into shares of common stock of the Company at the greater of $1.50 or fifty percent (50%) of the average closing bid price of the Company's common stock during the 20 days immediately following exercise thereof.

"The capital from this financing allows us to continue focusing on identifying and growing our targeted healthcare intellectual property acquisition opportunities," said Cris Grunewald, President and CEO of Spotlight Innovation. "This financing keeps us on track with our aggressive business plan goals, and with fulfilling our ultimate goal of having a positive impact on the health, well-being and quality-of-life of as many people as possible."

About Spotlight Innovation Inc.
Spotlight Innovation Inc. (OTCQB: STLT) specializes in identifying, acquiring and incubating companies which have unique intellectual property (IP) in the medical sector. The Company utilizes relationships with the nation's leading academic and institutional IP developers to locate promising IP technologies with potential for market share capture. With our support, development, resources and strategic planning expertise, we believe we can develop IP that will have a positive effect on healthcare. We intend to partner with proven sector leaders on commercialization once technologies are fully developed. Additional information available at http://www.spotlightinnovation.com.

Forward Looking Statements
Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securities Act of 1933 and Rule 3b-6 under the Securities Exchange Act of 1934, and are subject to the safe harbor created by those rules. All statements, other than statements of fact, included in this release, including, without limitation, statements regarding potential future plans and objectives of the company, are forward-looking statements that involve risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Technical complications, which may arise, could prevent the prompt implementation of any strategically significant plan(s) outlined above. The Company undertakes no duty to revise or update any forward-looking statements to reflect events or circumstances after the date of this release.